pindolol has been researched along with sotalol in 67 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 49 (73.13) | 18.7374 |
1990's | 4 (5.97) | 18.2507 |
2000's | 6 (8.96) | 29.6817 |
2010's | 8 (11.94) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bultsma, T; Donné-Op den Kelder, GM; Rademaker, B; Timmerman, H | 1 |
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Pfeifer, S; Zimmer, C | 1 |
Salimi, M | 1 |
Levy, JV | 1 |
Meier, J | 1 |
Levy, B; Sadagopa Ramanujam, VM; Trieff, NM; Venkatasubramanian, N; Young, TR | 1 |
Frohlich, ED; Lohmöller, G; Lydtin, H | 1 |
Day, MD; Roach, AG | 1 |
Kiechel, JR; Meier, J | 1 |
Bellucci, R; Bonomi, L; Massa, F; Noya, E; Perfetti, S | 1 |
Bylund, DB; Charness, ME; Snyder, SH | 1 |
Baker, I; Das Gupta, DS; Sowton, E | 1 |
Boissier, JR; Giudicelli, JF; Lhoste, F | 1 |
Dubach, UC | 1 |
Larsen, A | 2 |
Delini-Stula, A; Meier, M | 1 |
Garvey, HL; Ram, N | 1 |
Collste, P | 1 |
Lindsay, DB; Matthews, ML; Pegg, GG; Sillence, MN; Spiers, WG | 1 |
Almgren, O; Duker, G; Nerme, V; Reid, J | 1 |
Beudin, P; Ducher, JL; Gibert, J; Kantelip, JP; Lauxerois, M; Pechadre, JC; Sabot, C; Trolese, JF | 1 |
Carrageta, MO; Raftery, EB | 1 |
Brownlee, WC; Durrington, PN; Large, DM | 1 |
Fishbein, L; Jackson, CD | 1 |
Albengres, E; Duche, JC; Riant, P; Tillement, JP; Urien, S | 1 |
Desager, JP; Harvengt, C; Heller, F; Hulhoven, R | 1 |
Turner, P | 1 |
Cheymol, G; Laubie, M; Mouillé, P; Schmitt, H | 2 |
Bak, IJ; Grobecker, H; Hellenbrecht, D; Lemmer, B; Wiethold, G | 1 |
Górka, Z | 1 |
Grobecker, H; Hellenbrecht, D; Lemmer, B; Wiethold, G | 1 |
Hellenbrecht, D; Lemmer, B; Palm, D; Wiethold, G | 1 |
Boakes, AJ; Boeree, BH | 1 |
Cheymol, G; Mouillé, P | 1 |
Prichard, BN | 1 |
Simpson, FO | 1 |
Horii, D; Imai, S; Kawada, T; Takeda, K | 1 |
Saameli, K | 1 |
Byon, KY; Fleckenstein, A; Grün, G; Kaufmann, R | 1 |
Johansson, SR; McCall, M; Vedin, JA; Wilhelmsson, C | 1 |
Giorgetti, F; Re, L; Rossini, L | 1 |
Kudo, Y; Sokabe, H; Zehr, JE | 1 |
Gerstenbrand, F; Klingler, D; Poewe, W | 1 |
Friedewald, WT; Frishman, WH; Furberg, CD | 2 |
Abed, J; Donaldson, R; Nashat, F; Taggart, P | 1 |
Battersby, LA; Cruickshank, JM; Prichard, BN | 1 |
Fishman, PH; Henneberry, RC; Parent, JB; Tallman, JF | 1 |
Andrew, RJ; Stephenson, RM | 1 |
Buckley, NA; Dawson, AH; Epid, D; Reith, DM; Sayer, GP; Whyte, IM | 1 |
12 review(s) available for pindolol and sotalol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Biotransformation and pharmacokinetics of beta-receptor blockaders].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Biotransformation; Ethanolamines; Humans; Isoproterenol; Kinetics; Levobunolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Sotalol | 1975 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
Hypertension and beta-blockers. Are they all the same?
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Labetalol; Metoprolol; Pindolol; Receptors, Adrenergic, alpha; Sotalol | 1985 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Beta-adrenergic receptor blocking drugs in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Alprenolol; Antithyroid Agents; Ethanolamines; Humans; Hyperthyroidism; Iodine Radioisotopes; Oxprenolol; Pindolol; Practolol; Premedication; Propranolol; Sotalol; Sympathomimetics; Thyroidectomy | 1974 |
Beta-adrenergic receptor blocking drugs in angina pectoris.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation; Ethanolamines; Exercise Test; Heart Rate; Humans; Oxprenolol; Oxygen Consumption; Physical Exertion; Pindolol; Practolol; Propranolol; Sotalol | 1974 |
Beta-adrenergic receptor blocking drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Antidepressive Agents; Antihypertensive Agents; Asthma; Diuretics; Drug Evaluation; Drug Therapy, Combination; Ganglionic Blockers; Heart Failure; Humans; Hypertension; Libido; Oxprenolol; Pindolol; Practolol; Propranolol; Psychopharmacology; Regional Blood Flow; Sotalol; Vasodilator Agents | 1974 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Time Factors; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Overdosage with beta-adrenergic blocking agents.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Atropine; Blood Glucose; Cardiovascular System; Central Nervous System; Drug Tolerance; Heart Rate; Humans; Kinetics; Oxprenolol; Pindolol; Propranolol; Respiration; Sotalol | 1984 |
6 trial(s) available for pindolol and sotalol
Article | Year |
---|---|
Comparative effects of beta adrenergic blocking drugs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Electrocardiography; Exercise Test; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Oxprenolol; Pindolol; Placebos; Practolol; Propranolol; Sotalol | 1975 |
[Central effects of five beta-adrenergic receptor blockers in healthy volunteers: a quantitative EEG study].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Brain; Carteolol; Electroencephalography; Humans; Male; Metoprolol; Monitoring, Physiologic; Pindolol; Sotalol | 1989 |
Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cholesterol; Cholesterol, HDL; Female; Half-Life; Heart Rate; Humans; Hyperlipoproteinemias; Lipoproteins; Lipoproteins, VLDL; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Sotalol; Triglycerides | 1985 |
Duration of action of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Humans; Metoprolol; Penbutolol; Physical Exertion; Pindolol; Propranolol; Regression Analysis; Rest; Sotalol; Time Factors; Timolol | 1980 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Time Factors; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
51 other study(ies) available for pindolol and sotalol
Article | Year |
---|---|
Mapping of the beta 2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states.
Topics: Cell Membrane; Cells, Cultured; Guanylyl Imidodiphosphate; Hydrogen Bonding; Iodocyanopindolol; Liver; Models, Molecular; Pindolol; Protein Conformation; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Female; In Vitro Techniques; Jejunum; Male; Muscle Contraction; Muscle, Smooth; Oxprenolol; Pindolol; Propranolol; Rabbits; Sotalol | 1975 |
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Topics: Adrenergic beta-Antagonists; Aging; Alprenolol; Animals; Blood Pressure; Hypertension; Male; Metoprolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Pulse; Rats; Rats, Inbred Strains; Sodium Chloride; Sotalol; Stereoisomerism; Time Factors | 1976 |
Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Biological Availability; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Protein Binding; Sotalol; Timolol | 1977 |
Structure-activity relationships of some selected beta-adrenergic blocking agents--oxidation with N-bromosuccinimide.
Topics: Adrenergic beta-Antagonists; Bromosuccinimide; Butoxamine; Dose-Response Relationship, Drug; Ethanolamines; Kinetics; Molecular Conformation; Pindolol; Practolol; Propranolol; Sotalol; Structure-Activity Relationship; Succinimides | 1976 |
[Antihypertensive and hemodynamic effects of beta-receptor blockaders with various action spectra].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Hemodynamics; Humans; Hypertension; Pindolol; Placebos; Practolol; Propranolol; Sotalol | 1976 |
The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Blood Pressure; Brain; Cats; Female; Heart Rate; Injections, Intraventricular; Male; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol | 1975 |
Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Drug Tolerance; Ethanolamines; Intraocular Pressure; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rabbits; Sotalol; Timolol | 1979 |
Beta adrenergic receptor labeling in intact animals with 125I-hydroxybenzylpindolol.
Topics: Animals; Binding Sites; Brain Chemistry; Iodine Radioisotopes; Liver; Lung; Methods; Mice; Myocardium; Phentolamine; Pindolol; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Sotalol | 1977 |
Beta-adrenergic blockade and atrio--ventricular conduction impairment.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Atrioventricular Node; Dogs; Electric Stimulation; Electrocardiography; Female; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Pindolol; Practolol; Propranolol; Refractory Period, Electrophysiological; Sotalol; Stereoisomerism | 1975 |
[Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Vessels; Ethanolamines; Heart; Humans; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Sympathomimetics | 1975 |
On the neuromuscular effects of pindolol and sotalol in the rat.
Topics: Action Potentials; Animals; Membrane Potentials; Motor Endplate; Muscle Contraction; Neuromuscular Junction; Pindolol; Rats; Sotalol | 1978 |
Effects of pindolol, sotalol and the optical isomers of propranolol on muscle action potentials and depolarization-secretion coupling in the rat.
Topics: Action Potentials; Animals; Motor Endplate; Muscles; Neuromuscular Junction; Pindolol; Propranolol; Rats; Sotalol | 1978 |
Inhibitory effects of propranolol and oxprenolol on excitation induced by a MAO inhibitor and reserpine in the mouse.
Topics: Amphetamines; Animals; Male; Mice; Monoamine Oxidase Inhibitors; Motor Activity; Oxprenolol; Pargyline; Pindolol; Propranolol; Reserpine; Sotalol; Time Factors | 1976 |
Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Brain Chemistry; Female; Heart Rate; Injections, Subcutaneous; Liver; Lung; Male; Myocardium; Pindolol; Propranolol; Rats; Sotalol | 1975 |
[Dosage spacing in hypertension].
Topics: Humans; Hypertension; Pindolol; Practolol; Propranolol; Sotalol | 1976 |
Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on beta 2-adrenoceptor density in female rats.
Topics: Adrenergic beta-Antagonists; Animals; Clenbuterol; Eating; Female; Heart; Hindlimb; Iodine Radioisotopes; Iodocyanopindolol; Muscle Development; Muscles; Myocardium; Organ Size; Pindolol; Propanolamines; Rats; Receptors, Adrenergic, beta; Sotalol | 1991 |
(+)-sotalol causes significant occupation of beta-adrenoceptors at concentrations that prolong cardiac repolarization.
Topics: Action Potentials; Animals; Guinea Pigs; Heart; In Vitro Techniques; Iodine Radioisotopes; Myocardial Contraction; Papillary Muscles; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; Sotalol; Stereoisomerism | 1990 |
High plasma protein binding as a parameter in the selection of betablockers for lactating women.
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Proteins; Female; Humans; Hypertension; Lactation; Milk, Human; Pindolol; Pregnancy; Propanolamines; Propranolol; Protein Binding; Sotalol | 1986 |
Beta-blocking agents and plasma lipids: an update.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, LDL; Oxprenolol; Penbutolol; Pindolol; Sotalol | 1987 |
[Comparative study of chronotropic and inotropic effects of different beta adrenolytic drugs].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Animals; Bradycardia; Dogs; Drug Antagonism; Female; Guinea Pigs; Heart; Heart Atria; Heart Conduction System; Heart Rate; Injections, Intramuscular; Injections, Intravenous; Male; Pindolol; Propranolol; Propylamines; Reserpine; Sotalol | 1972 |
Human blood platelets as cellular models for investigation of membrane active drugs: beta-adrenergic blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Biological Transport; Blood Platelets; Carbon Isotopes; Cell Membrane Permeability; Humans; Kinetics; Microscopy, Electron; Models, Biological; Oxprenolol; Pindolol; Propranolol; Serotonin; Serotonin Antagonists; Sotalol; Tritium | 1972 |
Analysis of the hemodynamic action of beta-adrenolytics in narcotized cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Cats; Chemical Phenomena; Chemistry; Female; Hemodynamics; Male; Oxprenolol; Pindolol; Propranolol; Sotalol | 1973 |
Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
Topics: 1-Propanol; Absorption; Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Anesthetics, Local; Animals; Anura; Butylamines; Cresols; Ethanolamines; Heart Conduction System; In Vitro Techniques; Membranes; Nitrobenzenes; Oxprenolol; Phenethylamines; Phenols; Pindolol; Propranolol; Propylamines; Sotalol; Structure-Activity Relationship; Surface Tension; Surface-Active Agents; Water | 1973 |
Membrane effects of beta-adrenergic blocking agents: investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Aniline Compounds; Binding Sites; Blood Proteins; Dose-Response Relationship, Drug; Erythrocytes; Hemolysis; Humans; In Vitro Techniques; Membranes; Naphthalenes; Pindolol; Propranolol; Sotalol; Spectrometry, Fluorescence; Sulfonic Acids | 1973 |
[Inotropic effects of several adrenergic beta blockers in a dog subjected to electrosystolic cardiac impulse].
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Butylamines; Depression, Chemical; Dogs; Female; Heart Rate; Male; Nitriles; Pacemaker, Artificial; Pindolol; Practolol; Propanolamines; Propranolol; Sotalol; Stimulation, Chemical; Sulfides | 1973 |
Letter: Suicidal attempts with beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Heart Rate; Humans; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Suicide | 1973 |
[Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Blood Pressure; Butylamines; Dogs; Epinephrine; Female; Heart Rate; Male; Nitriles; Pindolol; Propanolamines; Propranolol; Sotalol; Sulfides; Yohimbine | 1973 |
Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Butylamines; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Methoxamine; Muscle Contraction; Muscle, Smooth; Oxprenolol; Phenyl Ethers; Pindolol; Practolol; Propanolamines; Propranolol; Receptors, Drug; Sotalol; Trachea | 1974 |
Pharmacological characterisation of -receptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Cats; Ethanolamines; Guinea Pigs; Heart Rate; Isoproterenol; Pindolol; Propranolol; Sotalol | 1972 |
[Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
Topics: Adrenergic beta-Antagonists; Allyl Compounds; Amino Alcohols; Animals; Calcium; Cats; Chick Embryo; Female; Guinea Pigs; Heart; Muscle Contraction; Muscle, Smooth; Papillary Muscles; Pindolol; Potassium; Prenylamine; Propranolol; Propylamines; Rabbits; Rats; Sotalol; Uterus; Verapamil | 1972 |
[Cholinergic antagonism by beta-blockers. I. Spectrum of interactions].
Topics: Abdominal Muscles; Acetylcholine; Adrenergic beta-Antagonists; Animals; Guinea Pigs; Heart; Ileum; Isoproterenol; Labetalol; Male; Metoprolol; Pindolol; Practolol; Propranolol; Receptors, Cholinergic; Sotalol | 1980 |
A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cardiovascular System; Female; Heart Rate; Isoproterenol; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Sotalol | 1981 |
[Therapy of essential tremor with special reference to the use of beta-blockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bupranolol; Double-Blind Method; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Prognosis; Propranolol; Sotalol; Tremor | 1982 |
Class III action of beta-blocking agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Atenolol; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Heart; Heart Ventricles; Male; Nadolol; Oxprenolol; Pindolol; Propanolamines; Propranolol; Sotalol; Timolol | 1984 |
Appearance of beta-adrenergic receptors and catecholamine-responsive adenylate cyclase activity during fusion of avian embryonic muscle cells.
Topics: Adenylyl Cyclases; Animals; Cell Fusion; Cholera Toxin; Coturnix; Isoproterenol; Muscles; Pindolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Sotalol | 1980 |
The effects of 5-HT receptor blockade on memory formation in the chick: possible interactions between beta-adrenergic, and serotonergic systems.
Topics: Adrenergic beta-Antagonists; Animals; Avoidance Learning; Chickens; Conditioning, Operant; Indoles; Ketanserin; Male; Memory; Pindolol; Receptors, Adrenergic, beta; Receptors, Serotonin; Serotonin Antagonists; Sotalol; Tropisetron | 1994 |
Relative toxicity of beta blockers in overdose.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child, Preschool; Databases, Factual; Drug Overdose; Female; Humans; Infant; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Prospective Studies; Seizures; Sotalol | 1996 |